TRIPS The India South Africa Proposal: Strengths & WeaknessesOctober 29, 2020 On October 2, 2020, India and South Africa jointly tabled a proposal titled Waiver From…Srividhya Ragavan PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
Data ExclusivitiesTRIPS Data Exclusivity and Trips Flexibilities: Going Back to the BasicsAugust 18, 2020 The COVID-19 pandemic has provided enough food for thought to reconsider public healthcare issues and…Sonal Singh Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
TRIPSTRIPS Flexibilities Beyond Data Exclusivities: Redefining Access to “Necessary Data” in the Era of COVID-19July 20, 2020 We are in the Age of Data. As fights grow to secure greater open access…Doris Estelle Long PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
COVID-19Experimental UsePatentsTRIPS Making Sure Patent Rights Create Space for R&D against the Coronavirus (COVID-19)May 18, 2020 Welcome to our first installment of TradeRX Reports. We first began discussing a blog dedicated…Doris Estelle Long COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
COVID-19TRIPS COVID-19 Should Change the U.S. Posture on Global Access to MedicationMay 18, 2020 The U.S. has long deferred to pharmaceutical companies on questions of pricing and availability of…Micheal PalmedoSrividhya Ragavan COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure System Patents and Trade: Opportunities and Challenges in the Global Healthcare Market CATEGORIES COVID-19 13 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 13 TRIPS Flexibilities 2 Vaccines 1 Voluntary Licenses 1
COVID-19TRIPS COVID-19 Throws Harsh Spotlight on The Human Cost of Misguided International Trade & IP PoliciesMay 18, 2020 The current global struggle with the Coronavirus pandemic has highlighted dangerous shortcomings of our healthcare…Srividhya RagavanDoris Estelle Long 1 2 Next